Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
16.12
-1.06 (-6.17%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $864.52 million as of September 11, 2026. Its market cap has increased by 496.63% in one year.
Market Cap
864.52M
Enterprise Value
464.48M
1-Year Change
496.63%
Ranking
Category
Stock Price
$16.12
ChartMarket Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $864.52M, an increase of 2,405.84%. That is a compound annual growth rate of 34.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 864.50M | 162.53% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 915.57M |
| Wave Life Sciences | 904.45M |
| Olema Pharmaceuticals | 894.23M |
| Ardelyx | 892.09M |
| Lexicon Pharmaceuticals | 889.91M |
| Theravance Biopharma | 883.14M |
| Rigel Pharmaceuticals | 882.44M |
| Immix Biopharma | 868.49M |